David Laharie

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 633 citations

Inflammation, Anti-inflammatory, Gastroenterology +4

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean–Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 589 citations · Full text

Inflammation, Antimetabolite Therapy, Anti-inflammatory +5

Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Philippe Marteau, Marc Lémann, Philippe Seksik et al. · Gut · 2005 · 409 citations · Full text

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

Juliette Foucher, Laurent Cast ra, Pierre–Henri Bernard et al. · European Journal of Gastroenterology & Hepatology · 2006 · 379 citations

Diagnosis, Liver Stiffness, Cirrhosis +16

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Marc Lémann, Jean–Yves Mary, Bernard Duclos et al. · Gastroenterology · 2006 · 370 citations

Inflammation, Anti-inflammatory, Infliximab Plus Azathioprine +6